• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BXN:AU

0.0160 AUD 0.00000.00%

As of 23:58:14 ET on 11/23/2014.

Snapshot for Bioxyne Ltd (BXN)

Open: 0.0150 Day's Range: 0.0150 - 0.0160 Volume: 441,367
Previous Close: 0.0160 52wk Range: 0.0050 - 0.0370 1-Yr Rtn: +77.78%

Stock Chart for BXN

No chart data available.
  • BXN:AU 0.0160
  • 1D
  • 1M
  • 1Y
0.0160
Interactive BXN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BXN

Current P/E Ratio (ttm) 2.6667
Estimated P/E(-) -
Relative P/E vs. AS51 0.1458
Earnings Per Share (ttm) 0.0060
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 3.21
Shares Outstanding (M) 200.34
30 Day Average Volume 151,615
Price/Book (mrq) 7.8524
Price/Sale (ttm) 1.2852
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/02/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BXN

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for BXN

Bioxyne Limited operates as a biotechnology company. The Company specializes in the research, development and commercialization of diseases related to chronic obstructive pulmonary disease(COPD).

Jarrod Travers WhiteCFO/Secretary
More Company Profile & Key Executives for BXN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil